Research on aflibercept 8 mg reveals promising real-world outcomes for treating wet AMD and diabetic macular edema, enhancing vision and safety.
Diana Do, MD
Advertisement
Articles by Diana Do, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
2
Q&A: Stephen Tsang discusses outcomes in retinitis pigmentosa and Stargardt trials
3
Optigo: Lead anti-VEGF program advancing toward IND-enabling studies
4
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics
5
